Answers are grounded in this paper and cite their sources.
In addition to their established action of synthetic lethality in tumor cells, poly(ADP-ribose) polymerase inhibitors (PARPis) also orchestrate tumor immune microenvironment (TIME) that contributes to suppressing tumor growth. However, it remains not fully understood whether and how PARPis trigger tumor-targeting immune responses.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: